Mark Slevin
Overview
Explore the profile of Mark Slevin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
141
Citations
2420
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salagean A, Moldovan C, Slevin M
Gels
. 2025 Jan;
11(1).
PMID: 39852021
HA (hyaluronan) has been considered in recent years as a naturally occurring modifiable gel-like scaffold that has the capability to absorb and release drugs over an extended period of time...
2.
Straista M, Slevin M
Cureus
. 2024 Sep;
16(8):e67969.
PMID: 39347146
Alzheimer's disease (AD) pathogenesis is conditioned by the presence of amyloid beta (Aβ) and neuroinflammation. The gliovascular unit (GVU) illustrates the relationship between the vascular components of the brain and...
3.
Degens H, Paudyal A, Kwakkel G, Slevin M, Maas H
Physiol Rep
. 2024 Jul;
12(14):e16153.
PMID: 39016169
Stroke is not only associated with muscle weakness, but also associated with reduced muscle fatigue resistance and reduced desaturation during exercise that may be caused by a reduced oxidative capacity...
4.
Borodi P, Slevin M, Hopulele-Petri A, Crainic A, Pop P, Gavris I, et al.
Rom J Ophthalmol
. 2024 Jul;
68(2):143-147.
PMID: 39006337
This study aimed to investigate the potential connections between Alzheimer's Disease (AD) and diabetes. This is a cross-sectional study in which AD and diabetes patients sent by the Psychiatry and...
5.
Muresan S, Slevin M, Szasz E, Loghin A
Cureus
. 2024 Jun;
16(6):e63200.
PMID: 38938906
Introduction Inflammatory bowel diseases (IBDs), including ulcerative colitis (UC) and Crohn's disease (CD), represent chronic progressive inflammatory gastrointestinal disorders, without a single reference standard for their diagnosis. The histological assessment...
6.
Pastorello Y, Russo A, Banescu C, Caprio V, Gall Z, Potempa L, et al.
Cureus
. 2024 Jun;
16(5):e60682.
PMID: 38899254
Introduction The neurovascular unit (NVU), comprising vascular and glial cells along with neurons, is vital for maintaining the blood-brain barrier (BBB) and cerebral homeostasis. Dysfunction of the NVU is implicated...
7.
Muresan S, Slevin M
Cureus
. 2024 Apr;
16(4):e59009.
PMID: 38665135
Inflammatory bowel disease (IBD) refers to two chronic conditions of the digestive tract: ulcerative colitis (UC) and Crohn's disease (CD), representing a progressive inflammatory process that mainly occurs in the...
8.
Heidari N, Olgiati S, Meloni D, Parkin J, Fish B, Slevin M, et al.
Cureus
. 2024 Apr;
16(3):e55832.
PMID: 38590455
Objective To identify key variables predictive of patient responses to microfragmented adipose tissue (MFAT) treatment in knee osteoarthritis (KOA) and evaluate its potential to delay or mitigate the need for...
9.
Pastorello Y, Manu D, Sawkulycz X, Caprio V, Banescu C, Dobreanu M, et al.
Int J Mol Sci
. 2024 Mar;
25(6).
PMID: 38542070
Monomeric C-reactive protein (mCRP) has recently been implicated in the abnormal vascular activation associated with development of atherosclerosis, but it may act more specifically through mechanisms perpetuating damaged vessel inflammation...
10.
Bartra C, Yuan Y, Vuraic K, Valdes-Quiroz H, Garcia-Baucells P, Slevin M, et al.
Antioxidants (Basel)
. 2024 Feb;
13(2).
PMID: 38397775
Resveratrol is a natural phenolic compound with known benefits against neurodegeneration. We analyzed in vitro the protective mechanisms of resveratrol against the proinflammatory monomeric C-reactive protein (mCRP). mCRP increases the...